Carbamic acid, with the specified name and CAS number 156672-01-4, is a complex organic compound characterized by its unique structural features, including a carbamic acid functional group and a tricyclic structure. This compound contains multiple functional groups, including an indole moiety and a hydroxycyclohexyl group, which contribute to its potential biological activity. The presence of the carbamate ester linkage suggests that it may exhibit properties typical of both carbamates and esters, such as potential reactivity with nucleophiles and stability under certain conditions. The stereochemistry indicated by the (1S-(1-alpha(S*),2-beta)) notation suggests specific spatial arrangements of atoms, which can influence the compound's interactions and biological effects. Overall, this compound may be of interest in medicinal chemistry and pharmacology, particularly for its potential applications in drug development, although specific biological activities and properties would require further investigation through experimental studies.

Carbamic acid, (2-((2-hydroxycyclohexyl)amino)-1-(1H-indol-3-ylmethyl)-1-methyl-2-oxoethyl)-,tricyclo(3.3.1(sup 3,7))dec-2-yl ester, (1S-(1-alpha(S*),2-beta))-

156672-01-4: Carbamic acid, with the specified name and CAS number 156672-01-4, is a complex organic compound characterized by its unique structural features, including a carbamic acid functional group and a tricyclic structure. This compound contains multiple functional groups, including an indole moiety and a hydroxycyclohexyl group, which contribute to its potential biological activity. The presence of the carbamate ester linkage suggests that it may exhibit properties typical of both carbamates and esters, such as potential reactivity with nucleophiles and stability under certain conditions. The stereochemistry indicated by the (1S-(1-alpha(S*),2-beta)) notation suggests specific spatial arrangements of atoms, which can influence the compound's interactions and biological effects. Overall, this compound may be of interest in medicinal chemistry and pharmacology, particularly for its potential applications in drug development, although specific biological activities and properties would require further investigation through experimental studies.

<p>CI-1015 is a CCK-B receptor antagonist with oral activity.</p>

CAS 156672-01-4

Carbamic acid, (2-((2-hydroxycyclohexyl)amino)-1-(1H-indol-3-ylmethyl)-1-methyl-2-oxoethyl)-,tricyclo(3.3.1(sup 3,7))dec-2-yl ester, (1S-(1-alpha(S*),2-beta))-

CI-1015

Ref: TM-T27014